The most common grade 3/4 treatment-related adverse events in MTC patients from the LIBRETTO-001 study were as follows: hypertension (12%), increased ALT (11%), increased AST (8%), diarrhea (3%), and prolonged QT (2%). Here, GPT is linked to medullary thyroid gland carcinoma.